Literature DB >> 21486742

Cytokine storm arising on the ocular surface in a patient with Stevens-Johnson syndrome.

Tomohito Yagi, Chie Sotozono, Masami Tanaka, Masahiro Fuwa, Eiichi Sekiyama, Mayumi Ueta, Kei Tashiro, Shigeru Kinoshita.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21486742     DOI： 10.1136/bjo.2010.196295

Source DB:  PubMed          Journal:  Br J Ophthalmol        ISSN： 0007-1161            Impact factor:   4.638


× No keyword cloud information.
  5 in total

1.  Neutrophil collagenase, gelatinase, and myeloperoxidase in tears of patients with stevens-johnson syndrome and ocular cicatricial pemphigoid.

Authors:  Samer N Arafat; Ana M Suelves; Sandra Spurr-Michaud; James Chodosh; C Stephen Foster; Claes H Dohlman; Ilene K Gipson
Journal:  Ophthalmology       Date:  2013-08-17       Impact factor: 12.079

2.  Downregulation of interferon-γ-induced protein 10 in the tears of patients with Stevens-Johnson syndrome with severe ocular complications in the chronic stage.

Authors:  Mayumi Ueta; Hiromi Nishigaki; Chie Sotozono; Shigeru Kinoshita
Journal:  BMJ Open Ophthalmol       Date:  2017-08-07

3.  Clinical parameters and biological markers associated with acute severe ocular complications in Stevens-Johnson syndrome and toxic epidermal necrolysis.

Authors:  Rawiphan Panpruk; Vilavun Puangsricharern; Jettanong Klaewsongkram; Pawinee Rerknimitr; Thanachaporn Kittipibul; Yuda Chongpison; Supranee Buranapraditkun
Journal:  Sci Rep       Date:  2021-10-12       Impact factor: 4.379

4.  Effect of age and early intervention with a systemic steroid, intravenous immunoglobulin or amniotic membrane transplantation on the ocular outcomes of patients with Stevens-Johnson syndrome.

Authors:  Kyeong Hwan Kim; Sung Wook Park; Mee Kum Kim; Won Ryang Wee
Journal:  Korean J Ophthalmol       Date:  2013-09-10

5.  Predictive biomarkers for the progression of ocular complications in chronic Stevens-Johnson syndrome and toxic Eeidermal necrolysis.

Authors:  Yamato Yoshikawa; Mayumi Ueta; Hiromi Nishigaki; Shigeru Kinoshita; Tsunehiko Ikeda; Chie Sotozono
Journal:  Sci Rep       Date:  2020-11-03       Impact factor: 4.379
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.